Click here to learn more about GRANI Cares - our patient co-pay program.

Scared of nausea and vomiting due to chemotherapy? You’re not alone.

If you’re undergoing chemotherapy or radiation therapy, there’s a strong possibility that these therapies can make you feel very sick. That’s why GRANISOL™ was created – to help control nausea and vomiting for 24-hours with one dose -- and provide patients with more hope associated with these important therapies.

GRANISOL is easy.

Some anti-nausea and anti-vomiting medicines require patients to take multiple doses within a day. Others require an IV to be put into your arm, while others are tablets – and not everyone can, or likes to take pills.

GRANISOL tastes like oranges and clinical trials have proven only 2mg of granisetron HCl controls vomiting in up to 77% of patients and nausea in about 50% of patients. GRANISOL provides 2mg of granisetron HCl in two teasponfuls. GRANISOL is the only FDA-approved oral solution containing granisetron, a medicine designed to calm the nerves that trigger vomiting.

GRANISOL is indicated for the prevention of:

  • Nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin.
  • Nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation.

Selected Safety Information:

  • GRANISOL is contraindicated in patients with known hypersensitivity to the drug or any of its components.
  • QT prolongation has been reported with granisetron. Therefore, GRANISOL Oral Solution should be used in caution with patients with pre-existing arrhythmias or cardiac conduction disorders, as this might lead to clinical consequences. Patients with cardiac disease, on cardio-toxic chemotherapy, with concomitant electrolyte abnormalities and/or on concomitant medications that prolong the QT interval are particularly at risk.
  • Safety and effectiveness in pediatric patients have not been established.
  • The most common side effects observed with administration of granisetron were headache, asthenia, constipation, diarrhea, dyspepsia, and abdominal pain.

Click here for full prescribing information.

GRANI Cares and Medicaid.

Often there are many financial pressures on patients which can make paying for anti-vomiting medicines difficult. This is why PediatRx has created our GRANI Cares Co-pay Assistance Program. Click here to learn more about this program offering eligible patients coverage on the cost of the co-pay, has no income ceiling, and has no limit on the number of prescriptions that qualify.

For patients enrolled in Medicaid, please contact your state Medicaid program to find out if GRANISOL is covered at the current time. Visit: http://www.cms.gov/MedicaidDrugRebateProgram/downloads/drugcon.pdf

Talk to your doctor about GRANISOL today.

GRANISOL is here to help patients with a brighter outlook on fighting cancer. Talk to your oncologist about prescribing GRANISOL to help control nausea and vomiting due to chemo- or radio-therapy.

The package insert requires Adobe®Reader® 9.X or higher. Download a free version at: http://get.adobe.com/reader.

GRANISOL


PediatRx.com | Terms and Conditions | Privacy Policy
©2012 PediatRx, Inc. All rights reserved. V3.06/11